Key facts
- Notable investors include Shanghai Houxue Private Equity Fund Management.
- Status: Privately Held (backing).
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Nurun Biomedical
- ·The full record, as it builds
Funding rounds
No funding rounds for Nurun Biomedical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nurun Biomedical
Provider of biotechnology services focused on nuclear medicine and biomedical research applications. The company provides nuclear medicine technologies, cell technology solutions, laboratory equipment, consumables and research services that serve biopharmaceutical companies and research institutions and enable medical research and therapeutic development.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Nurun Biomedical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nurun Biomedical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nurun Biomedical in its N-PORT filings yet. We sweep new filings monthly.